Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET, study published in … Novartis International AG / Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET, study published in NEJM shows Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the … Read more on wallstreet:online […]
Copyright © 2010 - Twitter Themes - All rights reserved. Conforms to W3C Standard XHTML & CSS